Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 23, Issue 10, 2008, Pages 3295-3301

  Latcha, Sheron ^a,b   Hong, Susana ^b   Gibbons, Nora ^b   Kohn, Nina ^c   Mattana, Joseph ^a,b,c  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Membrane transport; Peritoneal dialysis; Protein oxidation

Indexed keywords

ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LABORATORY TEST; MALE; MEMBRANE TRANSPORT; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; URINE VOLUME;

ADULT; AGED; ALBUMINS; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD PROTEINS; BLOTTING, WESTERN; DIALYSIS SOLUTIONS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PERITONEUM; PROTEINS; SERUM ALBUMIN;

EID: 52449091008     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn221     Document Type: Article

References (42)

1. Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens 2003; 12: 593-598
2. Vaziri ND. Oxidative stress in uremia: nature, mechanisms and potential consequences. Semin Nephrol 2004; 24: 469-473
3. Oberg BP, McMenamin E, Lucas FL et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004; 65: 1009-1016
4. Stadtman ER, Arai H, Berlett BS. Protein oxidation by the cytochrome P450 mixed-function oxidation system. Biochem Biophys Res Commun 2005; 338: 432-436
5. Stadtman ER. Protein oxidation in aging and age-related diseases. Ann NY Acad Sci 2001; 928: 22-38
6. Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res 2000; 33(Suppl): S99-S108
7. Teoh CY, Davies KJ. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis. Arch Biochem Biophys 2004; 423: 88-96
8. Naskalski JW, Marcinkiewicz J, Drozdz R. Myeloperoxidase-mediated protein oxidation: its possible biological functions. Clin Chem Lab Med 2002; 40: 463-468
9. Sohal RS. Role of oxidative stress and protein oxidation in the aging process. Free Radic Biol Med 2002; 33: 37-44
10. Mattana J, Margiloff L, Chaplia L et al. Metal-catalyzed oxidation of extracellular matrix increases macrophage nitric oxide generation. Kidney Int 1998; 54: 1581-1592
11. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1313
12. Donate T, Herreros A, Martinez E et al. Protein oxidative stress in dialysis patients. Adv Perit Dial 2002; 18: 15-17
13. Miyata T, Izuhara Y, Sakai H et al. Carbonyl stress: increased carbonyl modification of tissue and cellular proteins in uremia. Perit Dial Int 1999; 19(Suppl 2): S58-S61
14. Ahmed S, Gibbons N, Mattana J. Oxidized immunoglobulin G in patients with end-stage renal disease treated by hemodialysis. Ann Clin Lab Sci 2003; 33: 11-17
15. Witko-Sarsat V, Gausson V, Descamps-Latscha B. Are advanced oxidation protein products potential uremic toxins? Kidney Int Suppl 2003; 84: S11-S14
16. Drueke TB, Massy ZA. Advanced oxidation protein products, parathyroid hormone and vascular calcification in uremia. Blood Purif 2002; 20: 494-497
17. Ruiz MC, Portero-Otin M, Pamplona R et al. Chemical and immunological characterization of oxidative nonenzymatic protein modification in dialysis fluids. Perit Dial Int 2003; 23: 23-32
18. Flessner MF. Peritoneal ultrafiltration: mechanisms and measures. Contrib Nephrol 2006; 150: 28-36
19. Parikova A, Smit W, Struijk DG et al. Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int 2006; 70: 1988-1994
20. Noh H, Kim JS, Han KH et al. Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int 2006; 69: 2022-2028
21. Chow A, Ahmed S, Chaplia L et al. Measurement of immunoglobulin G oxidation by western blot analysis. In: Armstrong D (ed). Methods in Molecular Biology. Oxidants and Antioxidants. Ultrastructure and Molecular Biology Protocols, Vol. 196. Humana Press, Totawa, NJ, 2002, 163-169
22. Lo WK, Bargman JM, Burkart J et al. ISPD Adequacy of Peritoneal Dialysis Working Group. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int 2006; 26: 520-522
23. Flessner MF. The effect of fibrosis on peritoneal transport. Contrib Nephrol 2006; 150: 174-80
24. Bargman JM, Golper TA. The importance of residual renal function for patients on dialysis. Nephrol Dial Transplant 2005; 20: 671-673
25. Davies SJ, Brown EA, Frandsen NE et al. EAPOS Group. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 2005; 67: 1609-1615
26. Lameire N, Vanholder R, De Smet R. Uremic toxins and peritoneal dialysis. Kidney Int Suppl 2001; 78: S292-S297
27. Danielski M, Ikizler TA, McMonagle E et al. Linkage of hypoalbuminemia, inflammation and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis 2003; 42: 286-294
28. Gotloib L, Wajsbrot V, Cuperman Y et al. Acute oxidative stress induces peritoneal hyperpermeability, mesothelial loss, and fibrosis. J Lab Clin Med 2004; 143: 31-40
29. Korybalska K, Breborowicz A, Martis L et al. In vitro detection of hydrogen peroxide in mesothelial cells. Adv Perit Dial 1996; 12: 7-10
30. Yamaji Y, Nakazato Y, Oshima N et al. Oxidative stress induced by iron released from transferrin in low pH peritoneal dialysis solution. Nephrol Dial Transplant 2004; 19: 2592-2597
31. Lee HB, Yu MR, Song JS et al. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 2004; 65: 1170-1179
32. Grzybowski AE. Antioxidant mechanisms in human peritoneal mesothelial cells (HPMC) exposed in vitro to the constituents of dialysis fluid. Med Sci Monit 2000; 6: 232-239
33. Zeier M, Schwenger V, Deppisch R et al. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003; 63: 298-305
34. Shostak A, Pivnik E, Gotloib L. Cultured rat mesothelial cells generate hydrogen peroxide: a new player in peritoneal defense? J Am Soc Neph 1996; 7: 2371-2378
35. Nevado J, Peiro C, Vallejo S et al. Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells. Br J Pharmacol 2005; 146: 268-279
36. Schwenger V, Morath C, Salava A et al. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. J Am Soc Nephrol 2006; 17: 199-207
37. Boulanger E, Wautier MP, Wautier JL et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 2002; 61: 148-156
38. 2-generation bymononuclear phagocytes in diabetes. J Leukoc Biol 2007; 81: 520-527
39. Miyata T, Hori O, Zhang J et al. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2 microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 1996; 98: 1088-1094
40. Yamamoto Y, Kato I, Doi T et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 2001; 108: 261-268
41. Gunal AI, Celiker H, Ustundag B et al. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution. J Nephrol 2003; 16: 225-230
42. Stadtman ER. Protein oxidation and aging. Science 1992; 257: 1220-1224